The mechanism of chenodeoxycholic acid and its derivatives in hepatobiliary tumor

Chenodeoxycholic acid (CDCA) is a primary bile acid and is involved in the digestion, transportation, and absorption of nutriments in the hepatobiliary system. Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily. In vivo and in vitro studies have demonstrated that CDCA is the...

Full description

Bibliographic Details
Main Author: QI Fei
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2018-05-01
Series:Linchuang Gandanbing Zazhi
Subjects:
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=9073
Description
Summary:Chenodeoxycholic acid (CDCA) is a primary bile acid and is involved in the digestion, transportation, and absorption of nutriments in the hepatobiliary system. Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily. In vivo and in vitro studies have demonstrated that CDCA is the natural ligand for FXR and involved in many cell signaling pathways, and it can inhibit the proliferation and induce the apoptosis of hepatobiliary tumor cells. This article reviews the association between CDCA and hepatobiliary tumor.
ISSN:1001-5256
1001-5256